Which two types of antidiabetic agents decrease postprandial hyperglycemia? a. Sulfonylureas and biguanides b. Nonsulfonylureas (meglitinides) and sulfonylureas c. Biguanides and Alpha-glucosidase inhibitors d. TDZs, glitazones and alpha-glucosidase inhibitors e. Alpha-glucosidase inhibitors and DPP-4 inhibitors ab. DPP-4 inhibitors and GLP-Receptor agonists Which type (s) of antidiabetic agent (s) used to treat Type 2 diabetes is injected subcutancously? a. Sulfonylureas and GLP-1 Receptor agonists b. Nonsulfonylureas (meglitinides) and súlfonylureas c. Biguanides and Alpha-glucosidase inhibitors d. TDZs, glitazones and DPP- 4 inhibitors e. DPP- 4 inhibitors ab. GLP-1 Receptor agonists Which of the following applies to MICRO vascular disease? frequently causes retinopathy leading to blindness is related to elevated serum lipids leads to increased risk of myocardial infarction and peripheral vascular disease frequently causes nephropathy leading to kidney failure a. 1,3 b. 1,4 c.
[Solved]: Which two types of antidiabetic agents decrease…
Need help with your Cardiovascular Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.